Using Apollo Neuro in Autistic Children With Self-Injurious Behavior
NCT: NCT07648420 · NOT_YET_RECRUITING
Brief Summary
This study will evaluate the feasibility and acceptability of the Apollo Neuro, a wearable vibrotactile sensory device, in autistic children who engage in self-injurious behavior (SIB). Participants will wear the device for at least 3 hours per day over a 30-35 day period with caregiver support. Outcomes will include adherence to device use, caregiver-reported feasibility and acceptability, and descriptive characterization of caregiver-reported self- injurious and repetitive behaviors during the study period. This preliminary, single-group study is not designed to evaluate efficacy and will inform the design of future controlled trials.
Frequently Asked Questions
What is Using Apollo Neuro in Autistic Children With Self-Injurious Behavior?
Using Apollo Neuro in Autistic Children With Self-Injurious Behavior is a clinical trial registered under NCT07648420. Current status: NOT_YET_RECRUITING.
What is the status of NCT07648420?
The current status of NCT07648420 (Using Apollo Neuro in Autistic Children With Self-Injurious Behavior) is: NOT_YET_RECRUITING.
When did Using Apollo Neuro in Autistic Children With Self-Injurious Behavior start?
Using Apollo Neuro in Autistic Children With Self-Injurious Behavior started on 2026-12.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.